User profiles for Claudia Crimi

Claudia Crimi

Policlinico "G. Rodolico"- San Marco
Verified email at unict.it
Cited by 3689

A European survey of noninvasive ventilation practices

C Crimi, A Noto, P Princi, A Esquinas… - European respiratory …, 2010 - Eur Respiratory Soc
Although noninvasive ventilation (NIV) is becoming very popular, little is known about its
pattern of clinical and technical utilisation in different environments. We conducted a web-based …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

…, AL Kernder, S Monti, E Silvagni, C Crimi… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

[HTML][HTML] Determinants of tracheostomy decannulation: an international survey

HT Stelfox, C Crimi, L Berra, A Noto, U Schmidt… - Critical Care, 2008 - Springer
Background Although tracheostomy is probably the most common surgical procedure performed
on critically ill patients, it is unknown when a tracheostomy tube can be safely removed. …

High-flow nasal cannula and COVID-19: a clinical review

C Crimi, P Pierucci, T Renda, L Pisani… - Respiratory Care, 2022 - rc.rcjournal.com
During the coronavirus disease 2019 (COVID-19) pandemic, noninvasive respiratory
support has played a central role in managing patients affected by moderate-to-severe acute …

[HTML][HTML] Interleukins 4 and 13 in asthma: key pathophysiologic cytokines and druggable molecular targets

C Pelaia, E Heffler, C Crimi, A Maglio… - Frontiers in …, 2022 - frontiersin.org
Interleukins (IL)-4 and -13 play a pivotal role in the pathobiology of type-2 asthma. Indeed, IL-4
is crucially involved in Th2 cell differentiation, immunoglobulin (Ig) class switching and …

[HTML][HTML] Molecular targets for biological therapies of severe asthma

C Pelaia, C Crimi, A Vatrella, C Tinello… - Frontiers in …, 2020 - frontiersin.org
Asthma is a heterogeneous respiratory disease characterized by usually reversible bronchial
obstruction, which is clinically expressed by different phenotypes driven by complex …

[HTML][HTML] High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial

…, F Longhini, F Madotto, P Groff, R Scala, C Crimi… - Critical Care, 2020 - Springer
Background The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute
hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. …

[HTML][HTML] COVID‐19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments

…, A Papi, G Paoletti, G Malipiero, L Brussino, C Crimi… - Allergy, 2021 - ncbi.nlm.nih.gov
Claudia Crimi reports personal fees from Menarini. Daniela Morrone does not have any
conflict of interest to report. Marianna Padovani does not have any conflict of interest to report. …

[HTML][HTML] Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients

E Heffler, C Crimi, S Mancuso, R Campisi… - Respiratory …, 2018 - Elsevier
BACKGROUND The diagnosis of both asthma and chronic obstructive pulmonary disease (COPD)
consists of a combination of classical symptoms and signs, and the evidence of …

[HTML][HTML] Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy …

…, C Martinotti, F Blasi, C Bucca, N Crimi… - World Allergy …, 2019 - Elsevier
Background Asthma is one of the most common non-communicable respiratory diseases,
affecting about 6% of the general population. Severe asthma, even if afflicts a minority of …